Compare CVS Health Corp (CVS) vs State Street SPDR Bloomberg High Yield Bond ETF (JNK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs State Street SPDR Bloomberg High Yield Bond ETF — how do they compare? CVS Health Corp trades at $85.77 (market cap $112.29B), while State Street SPDR Bloomberg High Yield Bond ETF trades at $92.75 (market cap $5.86B). The key difference: CVS Health Corp is far larger — about 19.2× State Street SPDR Bloomberg High Yield Bond ETF's market cap, and CVS Health Corp pays a 3.03% dividend while State Street SPDR Bloomberg High Yield Bond ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold CVS Health Corp for 83 Days and State Street SPDR Bloomberg High Yield Bond ETF for 60 Days on average.
| CVS | JNK | |
|---|---|---|
Market Cap | $112.29B | $5.86B |
Volume | 7,763,676 | 7,780,002 |
Sector | Health | Fixed Income |
52-Week High | $110.60 | $98.02 |
52-Week Low | $70.08 | $92.30 |
Typical Hold Time | 83 Days | 60 Days |
Enterprise Value | $174.64B | — |
Dividend Yield | 3.03% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $87.95, up 1.76% with strong analyst support (85% buy ratings) and a $111.20 consensus price target suggesting 26% upside. Recent quarterly earnings consistently beat expectations, with Q2 2026 EPS of $2.58 surpassing the $1.85 estimate. Revenue growth remains solid at $402.07 billion for 2025, though net margins compressed to 1.18%. Technical indicators show a bullish overall signal with support at $87 and resistance at $89.
The outlook remains positive given CVS's dominant market position and Medicare expansion plans, but investors face risks from reimbursement pressures and ongoing legal investigations. Earnings growth and successful execution of healthcare services integration represent the primary catalysts for continued stock appreciation.
JNK trades at $92.76, down 0.13% with a bearish technical outlook indicated by moving averages. The ETF shows neutral oscillator signals with RSI at oversold levels. Recent corporate actions include consistent $0.53 dividend payments scheduled through October 2026. Market sentiment is influenced by rising bond yields and geopolitical tensions affecting high-yield bond markets.
The high-yield bond ETF faces headwinds from rising interest rates and inflation concerns, though consistent dividend payments provide income support. Key risks include further rate hikes and economic slowdown impacting junk bond performance. Institutional interest remains with recent position increases by asset managers.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About State Street SPDR Bloomberg High Yield Bond ETF
JNK is a major ETF tracking the Bloomberg High Yield Very Liquid Index. It provides exposure to U.S. dollar-denominated junk bonds with above-average liquidity, featuring 2026 top holdings like EchoStar, Cloud Software Group, and Carnival Corp.
Read more on JNK →
